The Winter 2020/21 issue of DDW is now available in print and via the DDW App, featuring the latest innovation and insight from the drug discovery and development community.
This season’s issue contains features on vaccines and immunology, AI and the US biotech sector plus expertise from companies such as PerkinElmer, Thermo Fisher Scientific and Scenic Biotech. We speak also exclusively to Twist Bioscience and CN Bio about the groundbreaking work they’re carrying out in the sector.
DDW, the longstanding first-choice publication for the drug discovery and development community now offers more content as well as more ways for you to access it – in print, online and via the App.
The Winter issue not only covers in-depth scientific research but it also contains intelligence to help you grow your business, spot the global opportunities and find the technology that will help you become increasingly competitive. Through market reports and opinion, DDW lets you get to know your industry in-depth and in detail.
Join DDW free today and become a member of Drug Discovery World
Readers can now become a member of DDW, for free. Membership includes:
Full access to the website including free and gated premium content in news, articles, business, regulatory, cancer research, intelligence and more.
Unlimited App access: current and archived digital issues of DDW magazine with search functionality, special in App only content and links to the latest industry news and information.
Weekly e-newsletter, a round-up of the most interesting and pertinent industry news and developments.
Whitepapers, eBooks and information from trusted third parties.
If you would like to become a member of DDW, please click here.